The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 31, 2022

Filed:

Mar. 12, 2020
Applicant:

Rush University Medical Center, Chicago, IL (US);

Inventors:

Kalipada Pahan, Skokie, IL (US);

Avik Roy, Chicago, IL (US);

Assignee:

RUSH UNIVERSITY MEDICAL CENTER, Chicago, IL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/22 (2006.01); A61K 31/16 (2006.01); G01N 33/68 (2006.01); G01N 33/50 (2006.01); A61K 31/19 (2006.01); A61P 25/28 (2006.01); A61P 3/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/22 (2013.01); A61K 31/16 (2013.01); A61K 31/19 (2013.01); A61P 3/00 (2018.01); A61P 25/28 (2018.01); G01N 33/5058 (2013.01); G01N 33/6896 (2013.01); G01N 2800/2814 (2013.01); G01N 2800/2835 (2013.01);
Abstract

Methods of modulating peroxisome proliferator-activated receptor α (PPARα) activity in a cell in a subject in need thereof are provided. The methods include administering an effective amount of a PPARα ligand to the subject where the PPARα ligand is selected from 3-hydroxy-2,2-dimethyl butyrate (HMB), hexadecananamide (HEX) and 9-octadecenamide (OCT). Methods of treating dementia, neurodegenerative disorders, lysosomal storage diseases and body weight disorders in a subject in need thereof are provided. The methods include administering an effective amount of a PPARα ligand to the subject.


Find Patent Forward Citations

Loading…